Altimmune, Inc.

Altimmune, Inc.verified

ALT

Price:

$5.31

Market Cap:

$468.65M

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryla...[Read more]

Industry

Biotechnology

IPO Date

2017-05-26

Stock Exchange

NASDAQ

Ticker

ALT

The Enterprise Value as of December 2025 (TTM) for Altimmune, Inc. (ALT) is 407.41M

According to Altimmune, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 407.41M. This represents a change of 32.20% compared to the average of 308.17M of the last 4 quarters.

Altimmune, Inc. (ALT) Historical Enterprise Value (quarterly & annually)

How has ALT Enterprise Value performed in the past?

The mean historical Enterprise Value of Altimmune, Inc. over the last ten years is 186.63M. The current 407.41M Enterprise Value has changed 21.73% with respect to the historical average. Over the past ten years (40 quarters), ALT's Enterprise Value was at its highest in in the December 2022 quarter at 712.97M. The Enterprise Value was at its lowest in in the December 2016 quarter at -122976004.80.

Quarterly (TTM)
Annual

Average

186.63M

Median

96.34M

Minimum

-122323459.60

Maximum

661.97M

Altimmune, Inc. (ALT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Altimmune, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 895.55%

Maximum Annual Enterprise Value = 661.97M

Minimum Annual Increase = -978.60%

Minimum Annual Enterprise Value = -122323459.60

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024476.69M2.61%
2023464.58M-29.82%
2022661.97M249.52%
2021189.39M8.17%
2020175.09M895.55%
201917.59M-164.25%
2018-27373036.08-263.30%
201716.76M-113.70%
2016-122323459.60-978.60%
201513.92M82.04%

Altimmune, Inc. (ALT) Average Enterprise Value

How has ALT Enterprise Value performed in the past?

The current Enterprise Value of Altimmune, Inc. (ALT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

534.41M

5-year avg

393.54M

10-year avg

186.63M

Altimmune, Inc. (ALT) Enterprise Value vs. Peers

How is ALT’s Enterprise Value compared to its peers?

Altimmune, Inc.’s Enterprise Value is greater than DBV Technologies S.A. (353.91M), less than Annexon, Inc. (432.32M), greater than Korro Bio, Inc. (74.88M), greater than enGene Holdings Inc. (396.46M), greater than Larimar Therapeutics, Inc. (299.00M), greater than Aura Biosciences, Inc. (320.33M), greater than Amarin Corporation plc (224.37M), greater than Alto Neuroscience, Inc. (272.30M), less than LB Pharmaceuticals Inc Common Stock (467.73M), greater than AC Immune S.A. (211.67M),

Build a custom stock screener for Altimmune, Inc. (ALT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Altimmune, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Altimmune, Inc. (ALT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Altimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Altimmune, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Altimmune, Inc. (ALT)?

What is the 3-year average Enterprise Value for Altimmune, Inc. (ALT)?

What is the 5-year average Enterprise Value for Altimmune, Inc. (ALT)?

How does the current Enterprise Value for Altimmune, Inc. (ALT) compare to its historical average?